These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32815582)

  • 21. Effect of oral tranexamic acid on erythema index in patients with melasma.
    Nguyen J; Rajgopal Bala H; Ross A; Wong CC; Paul E; Rodrigues M
    Australas J Dermatol; 2021 May; 62(2):206-209. PubMed ID: 33125702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
    Kaufman BP; Alexis AF
    J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma.
    Chaudhary S; Dayal S
    J Drugs Dermatol; 2013 Oct; 12(10):1149-53. PubMed ID: 24085051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural options for management of melasma, a review.
    Nomakhosi M; Heidi A
    J Cosmet Laser Ther; 2018; 20(7-8):470-481. PubMed ID: 29461133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
    Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
    Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Insights in Melasma and Hyperpigmentation Management.
    Huerth KA; Hassan S; Callender VD
    J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical Stabilized Cysteamine as a New Treatment for Hyperpigmentation Disorders: Melasma, Post-Inflammatory Hyperpigmentation, and Lentigines.
    Desai S; Hartman C; Grimes P; Shah S
    J Drugs Dermatol; 2021 Dec; 20(12):1276-1279. PubMed ID: 34898155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The top 10 cosmeceuticals for facial hyperpigmentation.
    Searle T; Al-Niaimi F; Ali FR
    Dermatol Ther; 2020 Nov; 33(6):e14095. PubMed ID: 32720446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Korean red ginseng powder in the treatment of melasma: an uncontrolled observational study.
    Song M; Mun JH; Ko HC; Kim BS; Kim MB
    J Ginseng Res; 2011 Jun; 35(2):170-5. PubMed ID: 23717059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tranexamic Acid in the Treatment of Melasma: A Review of the Literature.
    Perper M; Eber AE; Fayne R; Verne SH; Magno RJ; Cervantes J; ALharbi M; ALOmair I; Alfuraih A; Nouri K
    Am J Clin Dermatol; 2017 Jun; 18(3):373-381. PubMed ID: 28283893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemical peeling for treatment of Melasma, pigmentary disorders and hyperpigmentation : Indications, effectivity and risks].
    Borelli C; Fischer S
    Hautarzt; 2020 Dec; 71(12):950-959. PubMed ID: 33141276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma.
    Crocco EI; Veasey JV; Boin MF; Lellis RF; Alves RO
    Cutis; 2015 Nov; 96(5):337-42. PubMed ID: 26682557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of Oxidative Stress with Melasma: An Overview.
    Katiyar S; Yadav D
    Curr Pharm Des; 2022; 28(3):225-231. PubMed ID: 34736377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
    Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
    Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blinded, placebo-controlled trial of oral Polypodium leucotomos extract as an adjunct to sunscreen in the treatment of melasma.
    Ahmed AM; Lopez I; Perese F; Vasquez R; Hynan LS; Chong B; Pandya AG
    JAMA Dermatol; 2013 Aug; 149(8):981-3. PubMed ID: 23740292
    [No Abstract]   [Full Text] [Related]  

  • 37. Bilirubin as a new antioxidant in melasma.
    Rahimi H; Mirnezami M; Yazdabadi A
    J Cosmet Dermatol; 2022 Nov; 21(11):5800-5803. PubMed ID: 35833375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single-blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma.
    Sobhi RM; Sobhi AM
    J Cosmet Dermatol; 2012 Mar; 11(1):65-71. PubMed ID: 22360337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of efficacy of products containing azelaic acid in melasma treatment.
    Mazurek K; Pierzchała E
    J Cosmet Dermatol; 2016 Sep; 15(3):269-82. PubMed ID: 27028014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photobiomodulation for melasma treatment: Integrative review and state of the art.
    Galache TR; Sena MM; Tassinary JAF; Pavani C
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12935. PubMed ID: 38018017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.